What's in Ahmed M Maged, MD's pipeline?

Ahmed M Maged, MD has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Ahmed M Maged, MD's portfolio?

Top competitors by shared drug class: Amsterdam UMC, location VUmc, Azienda Policlinico Umberto I, Bayer, Benaroya Research Institute, Bo-In Lee.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ahmed-m-maged-md.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Ahmed M Maged, MD — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ahmed M Maged, MD pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
picolax drops	picolax drops	marketed	Osmotic laxative	Colonic smooth muscle and osmotic effect	Gastroenterology

Therapeutic area mix

Gastroenterology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Amsterdam UMC, location VUmc · 1 shared drug class
Azienda Policlinico Umberto I · 1 shared drug class
Bayer · 1 shared drug class
Benaroya Research Institute · 1 shared drug class
Bo-In Lee · 1 shared drug class
Braintree Laboratories · 1 shared drug class
Brooke Army Medical Center · 1 shared drug class
Aboca Spa Societa' Agricola · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Ahmed M Maged, MD:

Cite this brief

Drug Landscape (2026). Ahmed M Maged, MD — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ahmed-m-maged-md. Accessed 2026-05-16.